Is dialysis a viable option for the older patient? Outcomes for patients starting dialysis aged 80 years or older

Blood Purification
Anthony IsaacsAndrew Davenport

Abstract

Maximum conservative management (MCM) has been proposed as an alternative care pathway for the increasing number of elderly patients with progressive chronic kidney disease. Retrospective analysis of patients aged ≥80 years of age, starting dialysis between 2000 and 2009 in a centre with an established MCM programme. Demographic data, baseline biochemical markers and survival were collected. 93 consecutive patients were studied; median age 83 years (IQR 81-86). 67 male, 32% diabetic. Median survival 46.5 months (range 0-107), with 1- and 5-year survival 78.5 and 38.3%, respectively. Factors predicting poorer survival were Caucasoid ethnicity (p = 0.04) and serum albumin ≤30 g/l (p = 0.01) at dialysis initiation. Duration of nephrology care prior to dialysis initiation did not effect survival. The very elderly electing dialysis were found to have good survival. Further patient characterisation is required to improve decision-making between dialysis and MCM for elderly patients with progressive chronic kidney disease.

References

Jun 9, 2000·Kidney International·W MetcalfeA M MacLeod
Feb 24, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S K MunshiG Warwick
Oct 30, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·U N PeriJ P Middleton
Mar 28, 2003·Journal of the American Society of Nephrology : JASN·Dominique JolyPaul Jungers
Dec 1, 2004·Kidney International·Shilpanjali PrasadDavid Taube
Feb 21, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nobuhiko JokiMasato Nakamura
Dec 14, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Melissa S Y ThongFriedo W Dekker
Apr 11, 2008·Journal of the American Society of Nephrology : JASN·Myles WolfRavi Thadhani
Dec 20, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Cécile CouchoudUNKNOWN French Renal Epidemiology and Information Network (REIN) registry
Feb 3, 2009·The American Journal of Medicine·Eric L EisensteinDaniel B Mark
Oct 8, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Rachel C CarsonAine Burns
Oct 16, 2009·The New England Journal of Medicine·Manjula Kurella TamuraCharles E McCulloch
Oct 16, 2009·The New England Journal of Medicine·Sarbjit Vanita JassalMichelle Hladunewich
Feb 23, 2010·Nephron. Clinical Practice·U VerdallesJ M López-Gómez
Aug 10, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Antje Fürstenberg, Andrew Davenport
Aug 31, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Konstadina GrivaStanton P Newman
Sep 18, 2010·Journal of Psychosomatic Research·Konstadina GrivaStanton Newman
Oct 6, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joseph ChilcotKen Farrington
Nov 10, 2010·Hemodialysis International·Aine Burns, Andrew Davenport
Jan 8, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ben CaplinAndrew Davenport

❮ Previous
Next ❯

Citations

Aug 25, 2015·Nefrología : publicación oficial de la Sociedad Española Nefrologia·José Luis TeruelCarlos Quereda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.